Your browser doesn't support javascript.
loading
BRAF V600E mutation in early-stage multiple myeloma: good response to broad acting drugs and no relation to prognosis.
Rustad, E H; Dai, H Y; Hov, H; Coward, E; Beisvag, V; Myklebost, O; Hovig, E; Nakken, S; Vodák, D; Meza-Zepeda, L A; Sandvik, A K; Wader, K F; Misund, K; Sundan, A; Aarset, H; Waage, A.
Afiliação
  • Rustad EH; 1] KG Jebsen Center for Myeloma Research, Norwegian University of Science and Technology, Trondheim, Norway [2] Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Dai HY; Department of Pathology and Medical Genetics, St Olavs Hospital, Trondheim, Norway.
  • Hov H; 1] Department of Pathology and Medical Genetics, St Olavs Hospital, Trondheim, Norway [2] Department of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology, Trondheim, Norway.
  • Coward E; 1] Bioinformatics Core Facility, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway [2] Norwegian Cancer Genomics Consortium, Norway.
  • Beisvag V; Bioinformatics Core Facility, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Myklebost O; 1] Norwegian Cancer Genomics Consortium, Norway [2] Department of Tumor Biology, Institute for Cancer Research, Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Hovig E; 1] Norwegian Cancer Genomics Consortium, Norway [2] Department of Tumor Biology, Institute for Cancer Research, Radium Hospital, Oslo University Hospital, Oslo, Norway [3] Institute for Cancer Genetics and Informatics, Radium Hospital, Oslo University Hospital, Oslo, Norway [4] Biomedical Informatic
  • Nakken S; 1] Norwegian Cancer Genomics Consortium, Norway [2] Department of Tumor Biology, Institute for Cancer Research, Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Vodák D; 1] Norwegian Cancer Genomics Consortium, Norway [2] Department of Tumor Biology, Institute for Cancer Research, Radium Hospital, Oslo University Hospital, Oslo, Norway [3] Bioinformatics Core facility, Institute for Cancer Research, Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Meza-Zepeda LA; 1] Norwegian Cancer Genomics Consortium, Norway [2] Department of Tumor Biology, Institute for Cancer Research, Radium Hospital, Oslo University Hospital, Oslo, Norway [3] Genomics Core facility, Institute for Cancer Research, Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Sandvik AK; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Wader KF; Department of Oncology, St Olavs Hospital, Trondheim, Norway.
  • Misund K; 1] KG Jebsen Center for Myeloma Research, Norwegian University of Science and Technology, Trondheim, Norway [2] Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Sundan A; 1] KG Jebsen Center for Myeloma Research, Norwegian University of Science and Technology, Trondheim, Norway [2] Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Aarset H; Department of Pathology and Medical Genetics, St Olavs Hospital, Trondheim, Norway.
  • Waage A; 1] KG Jebsen Center for Myeloma Research, Norwegian University of Science and Technology, Trondheim, Norway [2] Bioinformatics Core Facility, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway [3] Norwegian Cancer Genomics Consorti
Blood Cancer J ; 5: e299, 2015 Mar 20.
Article em En | MEDLINE | ID: mdl-25794135

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article